Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
160
-
Total 13F shares, excl. options
-
84.4M
-
Shares change
-
+1.38M
-
Total reported value, excl. options
-
$764M
-
Value change
-
+$19.6M
-
Put/Call ratio
-
1.01
-
Number of buys
-
72
-
Number of sells
-
-83
-
Price
-
$9.05
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q4 2019
205 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q4 2019.
Evolent Health, Inc. - Class A Common Stock (EVH) has 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 84.4M shares
of 112M outstanding shares and own 75.6% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6.89M shares), BlackRock Inc. (6.37M shares), JPMORGAN CHASE & CO (6.32M shares), DIMENSIONAL FUND ADVISORS LP (3.76M shares), CREDIT SUISSE AG/ (3.75M shares), WELLINGTON MANAGEMENT GROUP LLP (3.64M shares), Bellevue Group AG (3.55M shares), EAGLE ASSET MANAGEMENT INC (3.41M shares), RIVERBRIDGE PARTNERS LLC (2.9M shares), and CARILLON TOWER ADVISERS, INC. (2.8M shares).
This table shows the top 160 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.